Why Calls to Diversify Trial Populations Fall Short

Drawing on a SARS-CoV-2 vaccine trial in a Latinx community in San Diego, we show how trial designs fail to redress structural racism and may introduce new harms. While important, trial diversity alone cannot redress entrenched inequities that affect Black, Indigenous, and People of Color (BIPOC) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Varma, Saiba, Vora, Kalindi, Fox, Keolu, Berkhout, Suze, Benmarhnia, Tarik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759801/
https://www.ncbi.nlm.nih.gov/pubmed/35072131
http://dx.doi.org/10.1016/j.medj.2020.12.012
Descripción
Sumario:Drawing on a SARS-CoV-2 vaccine trial in a Latinx community in San Diego, we show how trial designs fail to redress structural racism and may introduce new harms. While important, trial diversity alone cannot redress entrenched inequities that affect Black, Indigenous, and People of Color (BIPOC) communities.

Ejemplares similares